Windlas Biotech Ltd.
NSE: WINDLAS | BSE: 543329
₹824.30
₹13.00
(1.60%)
As on 12-Jun-2026IST
Market cap
₹1,694 Cr
Revenue (TTM)
₹904 Cr
P/E Ratio
25.5
P/B Ratio
3.2
Div. Yield
0.8 %
Quality Score
8/10
Growth Score
6/10
Valuation Score
5/10
Momentum Score
6/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹66 Cr
-
ROE
12.9 %
-
ROCE
17.1 %
-
Industry P/E
34.68
-
EV/EBITDA
14.1
-
Debt to Equity
0
-
Book Value
₹258.7
-
EPS
₹31.6
-
Face value
5
-
Shares outstanding
20,636,229
10 Years Aggregate
CFO
₹343.32 Cr
EBITDA
₹504.16 Cr
Net Profit
₹320.41 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Windlas Biotech
| 3.7 | 3.2 | 11.0 | -10.8 | 43.8 | -- | -- |
|
BSE Healthcare
| 9.1 | 1.2 | 7.9 | 7.7 | 25.1 | 13.2 | 12.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Windlas Biotech
| -23.8 | 118.5 | 71.4 | -9.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Windlas Biotech
|
824.3 | 1,694.4 | 904.1 | 66.5 | 8.2 | 11.9 | 25.5 | 3.2 |
| 3,131.0 | 39,096.7 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 37 | 8.6 | |
| 8,249.5 | 20,609.8 | 2,275.6 | 187.5 | 10.3 | 22.9 | 109.9 | 23.6 | |
| 2,407.8 | 18,328.7 | 2,187.2 | 649.7 | 31.5 | 19 | 28.6 | 5.1 | |
| 1,728.3 | 10,570.9 | 1,196.4 | 149.4 | -- | 27.5 | 57.1 | 14.2 | |
| 1,404.6 | 19,439.6 | 3,129.4 | 647.4 | 26.9 | 18.1 | 31.4 | 5.0 | |
| 2,257.7 | 36,308.8 | 4,147.8 | 709.5 | 22.3 | 19.1 | 51.2 | 8.7 | |
| 4,509.2 | 20,631.8 | 2,519.7 | 722.4 | 33.6 | 18.8 | 28.6 | 4.9 | |
| 6,287.0 | 10,413.7 | 1,408.0 | 326.9 | 30.8 | 57.1 | 31.9 | 19.9 | |
| 546.8 | 10,682.7 | 1,538.1 | 226.2 | 20.4 | 9 | 43.9 | 4.1 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Sigachi Industries IPO: Information analysis
6 min read•By Arul Selvan and Udhayaprakash
3 min read•By Udhayaprakash
6 min read•By Arul Selvan
About Windlas Biotech
Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO services, including product discovery, product... development, licensing, and commercial manufacturing of generic products. It manufactures nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprises fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, and chewable or dispersible. The company was incorporated in 2001 and is based in Gurugram, India. Read more
-
Incorporated
2001
-
Chairman
Vivek Dhariwal
-
Managing Director
Hitesh Windlass
-
Headquarters
Dehradun, Uttarakhand
-
Website
Looking for more details about Windlas Biotech Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Windlas Biotech
What is the current share price of Windlas Biotech Ltd Today?
The share price of Windlas Biotech Ltd is ₹824.30 (NSE) and ₹821.10 (BSE) as of 12-Jun-2026 IST. Windlas Biotech Ltd has given a return of 43.83% in the last 3 years.
What is the current PB & PE ratio of Windlas Biotech Ltd?
The P/E ratio of Windlas Biotech Ltd is 25.50 times as on 12-Jun-2026, a 26 discount to its peers’ median range of 34.68 times.
The P/B ratio of Windlas Biotech Ltd is 3.17 times as on 12-Jun-2026, a 35 discount to its peers’ median range of 4.91 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
35.78
|
4.36
|
|
2024
|
18.31
|
2.39
|
|
2023
|
11.06
|
1.18
|
|
2022
|
12.02
|
1.17
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Windlas Biotech Ltd?
The 52-week high and low of Windlas Biotech Ltd are Rs 1,097.90 and Rs 697.40 as of 14-Jun-2026.
What is the market cap of Windlas Biotech Ltd?
Windlas Biotech Ltd has a market capitalisation of ₹ 1,694 Cr as on 12-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Windlas Biotech Ltd?
Before investing in Windlas Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.